TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32690472 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35410312 — Surrogate Endpoint (SUR): Blood pressure
Study 35199220 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34116715 — Predictive Biomarker (PRD): CXCR5 mRNA
Genes: CXCR5; BLR1; MDR15
Study 34940781 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34940781 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34940781 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32446164 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 34387827 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33899292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33899292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33899292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34071868 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34071868 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 34615636 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34615636 — Surrogate Endpoint (SUR): Complete renal response
Study 35798020 — Surrogate Endpoint (SUR): Bone mineral density
Study 33739437 — Safety Biomarker (SAF): BDNF
Study 32728536 — Surrogate Endpoint (SUR): Blood pressure
Study 34541720 — Predictive Biomarker (PRD): TBX21 mRNA
Genes: TBX21; TBET; TBLYM
Study 34541720 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study 34541720 — Predictive Biomarker (PRD): RORC mRNA
Genes: RORC; NR1F3; RORG; RZRG
Study 34541720 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 33144085 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 35325834 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35325834 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 33303119 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32419594 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 35761262 — Surrogate Endpoint (SUR): Blood pressure
Study 33085801 — Surrogate Endpoint (SUR): Blood pressure
Study 32196793 — Surrogate Endpoint (SUR): Blood pressure
Study 34556670 — Predictive Biomarker (PRD): KCNH6 mRNA
Genes: KCNH6; ERG2
Study 35261279 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32886131 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32886131 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32594760 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 32915426 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32915426 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 32600358 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 32600358 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 32600358 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32600358 — Surrogate Endpoint (SUR): Serum creatinine
Study 34625954 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 33438516 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33438516 — Surrogate Endpoint (SUR): Blood pressure
Study 35953245 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33203954 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 33203954 — Pharmacodynamic Biomarker (PDY): Auditory steady-state response
Study 35586820 — Predictive Biomarker (PRD): CXCL16 mRNA
Genes: CXCL16; SCYB16; SRPSOX; UNQ2759/PRO6714
Study 35586820 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35586820 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study 35586820 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34282568 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32415664 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study 35820631 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35820631 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 35820631 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study 35723814 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 32898271 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33991711 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33991711 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32522066 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32522066 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33273441 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 34840945 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33373666 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 33597136 — Surrogate Endpoint (SUR): Blood pressure
Study 32114331 — Predictive Biomarker (PRD): CGAS mRNA
Genes: CGAS; C6orf150; MB21D1
Study 32546646 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32546646 — Predictive Biomarker (PRD): Hormone receptor
Study 32546646 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35664249 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35664249 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35664249 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35664249 — Surrogate Endpoint (SUR): Blood pressure
Study 34495285 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34766424 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 32407717 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 32407717 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32407717 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32410849 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 32410849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36316421 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 32801009 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 32801009 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study 32801009 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study 32801009 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 32801009 — Predictive Biomarker (PRD): Angiopoietin-related protein 4
Genes: ANGPTL4; ARP4; HFARP; PGAR; PP1158; PSEC0166; UNQ171/PRO197
Study 34726293 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34726293 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34726293 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34726293 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 34726293 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 35115003 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35115003 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35115003 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35115003 — Surrogate Endpoint (SUR): Serum uric acid
Study 32305012 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32305012 — Safety Biomarker (SAF): BDNF
Study 34126291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33657443 — Surrogate Endpoint (SUR): Bone mineral density
Study 36256926 — Surrogate Endpoint (SUR): Blood pressure
Study 34429137 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 33079971 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 34493311 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32506857 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33716034 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 33716034 — Predictive Biomarker (PRD): NFKB2 mRNA
Genes: NFKB2; LYT10
Study 33079935 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33079935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33079935 — Surrogate Endpoint (SUR): Blood pressure
Study 36424116 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34097854 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34154896 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34518101 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34518101 — Safety Biomarker (SAF): IL-6 and IL-10
Study 36225301 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 32250418 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32250418 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35162622 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34898916 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33870762 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 33870762 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 33609624 — Predictive Biomarker (PRD): BORA mRNA
Genes: BORA; C13orf34
Study 32488909 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32488909 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32488909 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34224858 — Safety Biomarker (SAF): miR-16
Study 34224858 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 34224858 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study 35352014 — Surrogate Endpoint (SUR): Blood pressure
Study 33589759 — Surrogate Endpoint (SUR): Blood pressure
Study 35276789 — Surrogate Endpoint (SUR): Blood pressure
Study 35961692 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34613339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 36188617 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32778175 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32778175 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33040778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33040778 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 33040778 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 35217236 — Predictive Biomarker (PRD): GDF9 mRNA
Genes: GDF9
Study 35217236 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 33091433 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34419285 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34476847 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 32469138 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34324231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34324231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33352723 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study 33352723 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33352723 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35525132 — Surrogate Endpoint (SUR): Blood pressure
Study 32859608 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34324138 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 32847923 — Surrogate Endpoint (SUR): Serum potassium
Study 35560407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33836990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33836990 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36124638 — Predictive Biomarker (PRD): Microsatellite instability
Study 32835687 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34920291 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study 36396522 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36240638 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36240638 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 36240638 — Predictive Biomarker (PRD): CA2 mRNA
Genes: CA2
Study 36240638 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 36240638 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32369546 — Surrogate Endpoint (SUR): Blood pressure
Study 33663739 — Surrogate Endpoint (SUR): Serum creatinine
Study 34156097 — Surrogate Endpoint (SUR): Blood pressure
Study 33548002 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 32143061 — Surrogate Endpoint (SUR): Blood pressure
Study 32794131 — Safety Biomarker (SAF): Reactive oxygen species
Study 32794131 — Safety Biomarker (SAF): Cytochrome c
Study 32794131 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32579403 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 35598597 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 35598597 — Safety Biomarker (SAF): Reactive oxygen species
Study 32390731 — Surrogate Endpoint (SUR): Blood pressure
Study 33082202 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 33486990 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 33486990 — Surrogate Endpoint (SUR): Blood pressure
Study 32868661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32868661 — Surrogate Endpoint (SUR): Blood pressure
Study 35390727 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32211907 — Predictive Biomarker (PRD): GAL3ST1 mRNA
Genes: GAL3ST1; CST
Study 35488808 — Predictive Biomarker (PRD): MFF mRNA
Genes: MFF; C2orf33; AD030; AD033; GL004
Study 36442482 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36442482 — Surrogate Endpoint (SUR): Blood pressure
Study 34031547 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34031547 — Surrogate Endpoint (SUR): Blood pressure
Study 35912517 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35912517 — Safety Biomarker (SAF): BDNF
Study 33794080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33794080 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 35065931 — Surrogate Endpoint (SUR): Blood pressure
Study 33982949 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 33688713 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 33688713 — Surrogate Endpoint (SUR): Probing pocket depth
Study 35349835 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33431358 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 34423361 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34325134 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34325134 — Surrogate Endpoint (SUR): Blood pressure
Study 34325134 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32990607 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35448942 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 35448942 — Surrogate Endpoint (SUR): Blood pressure
Study 33169175 — Surrogate Endpoint (SUR): Bone mineral density
Study 32685258 — Surrogate Endpoint (SUR): Blood pressure
Study 33827781 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 33152119 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study 33152119 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35422208 — Surrogate Endpoint (SUR): Blood pressure
Study 33638248 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32594135 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 34320250 — Predictive Biomarker (PRD): FAIM mRNA
Genes: FAIM; FAIM1
Study 33374465 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 33374465 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33098992 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33098992 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 33098992 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 32151211 — Surrogate Endpoint (SUR): Bone mineral density
Study 35608106 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 33070288 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 36271804 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study 36271804 — Predictive Biomarker (PRD): CCL26 mRNA
Genes: CCL26; SCYA26; UNQ216/PRO242
Study 36271804 — Predictive Biomarker (PRD): CCL24 mRNA
Genes: CCL24; MPIF2; SCYA24
Study 33903925 — Surrogate Endpoint (SUR): Bone mineral density
Study 34302514 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 34302514 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 34724045 — Surrogate Endpoint (SUR): Blood pressure
Study 32507136 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 33307546 — Predictive Biomarker (PRD): OAS1 mRNA
Genes: OAS1; OIAS
Study 33307546 — Predictive Biomarker (PRD): OAS2 mRNA
Genes: OAS2
Study 33307546 — Predictive Biomarker (PRD): OAS3 mRNA
Genes: OAS3; P/OKcl.4
Study 33307546 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 33307546 — Predictive Biomarker (PRD): DPP9 mRNA
Genes: DPP9; DPRP2
Study 33307546 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 36175722 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 32498637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32498637 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34186201 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33742652 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35834624 — Surrogate Endpoint (SUR): Blood pressure
Study 35451096 — Surrogate Endpoint (SUR): Blood pressure
Study 32039840 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34329947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34263416 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34615782 — Surrogate Endpoint (SUR): Bacterial count
Study 34496751 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 35233984 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 35373021 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 33715648 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 33715648 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 32985369 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 32985369 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35060544 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 34000245 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 34000245 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 34000245 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 34475187 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33567888 — Surrogate Endpoint (SUR): Blood pressure
Study 33567888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36085679 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 34547013 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 36274214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36274214 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 36274214 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35584872 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 35584872 — Surrogate Endpoint (SUR): Blood pressure
Study 34271175 — Surrogate Endpoint (SUR): Blood pressure
Study 34271175 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33016688 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34184784 — Surrogate Endpoint (SUR): Bone mineral density
Study 34010180 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33259846 — Predictive Biomarker (PRD): PON2 mRNA
Genes: PON2
Study 33259846 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 33303575 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 33303575 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36168844 — Predictive Biomarker (PRD): HR mRNA
Genes: HR